Watershed Therapeutics Overview
- Year Founded
-
2019

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Series 2
- Latest Deal Amount
-
$2M
- Investors
-
10
Watershed Therapeutics General Information
Description
Developer of a novel targeted drug-delivery technology designed to provide treatment for bladder diseases. The company's technology focuses on utilizing treatment and prophylaxis, acute and chronic therapy, delivery of larger drug payload, and other related medical services, enabling clinicians or healthcare professionals to help their patients in improving their quality of life.
Contact Information
Website
www.watershedtx.comCorporate Office
- 9841 North East 15th Street
- Bellevue, WA 98004
- United States
Corporate Office
- 9841 North East 15th Street
- Bellevue, WA 98004
- United States
Watershed Therapeutics Timeline
Watershed Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Seed Round | 07-Apr-2023 | $2M | Completed | Clinical Trials - Phase 1 | ||
2. Accelerator/Incubator | 01-Sep-2022 | Completed | Pre-Clinical Trials | |||
1. Seed Round | 15-Aug-2022 | $2.48M | $2.48M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Watershed Therapeutics Comparisons
Industry
Financing
Details
Watershed Therapeutics Competitors (2)
One of Watershed Therapeutics’s 2 competitors is Urogen Pharma, a Formerly VC-backed company based in Princeton, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Urogen Pharma | Formerly VC-backed | Princeton, NJ | ||||
Taris Biomedical | Corporation | Woburn, MA |
Watershed Therapeutics Patents
Watershed Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023255693-A1 | Formulation for treating urinary system disorders | Pending | 19-Apr-2022 | ||
CA-3214668-A1 | Formulation and method for treatment of urinary system disorders | Pending | 07-Apr-2021 | ||
EP-4319724-A1 | Formulation and method for treatment of urinary system disorders | Pending | 07-Apr-2021 | ||
AU-2021439740-A1 | Formulation and method for treatment of urinary system disorders | Pending | 07-Apr-2021 | ||
US-20240189237-A1 | Formulation and method for treatment of urinary system disorders | Pending | 07-Apr-2021 | A61K31/635 |
Watershed Therapeutics Signals
Watershed Therapeutics Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Charleston Angel Partners | Angel Group | Minority | ||
Serial Stage Venture Partners | Venture Capital | Minority | ||
Sierra Angels | Angel Group | Minority | ||
WTIA Startup Program | Accelerator/Incubator | |||
4i Ventures | Venture Capital | Minority |
Watershed Therapeutics FAQs
-
When was Watershed Therapeutics founded?
Watershed Therapeutics was founded in 2019.
-
Where is Watershed Therapeutics headquartered?
Watershed Therapeutics is headquartered in Bellevue, WA.
-
What is the size of Watershed Therapeutics?
Watershed Therapeutics has 5 total employees.
-
What industry is Watershed Therapeutics in?
Watershed Therapeutics’s primary industry is Drug Discovery.
-
Is Watershed Therapeutics a private or public company?
Watershed Therapeutics is a Private company.
-
What is the current valuation of Watershed Therapeutics?
The current valuation of Watershed Therapeutics is
. -
What is Watershed Therapeutics’s current revenue?
The current revenue for Watershed Therapeutics is
. -
How much funding has Watershed Therapeutics raised over time?
Watershed Therapeutics has raised $4.48M.
-
Who are Watershed Therapeutics’s investors?
Charleston Angel Partners, Serial Stage Venture Partners, Sierra Angels, WTIA Startup Program, and 4i Ventures are 5 of 10 investors who have invested in Watershed Therapeutics.
-
Who are Watershed Therapeutics’s competitors?
Urogen Pharma and Taris Biomedical are competitors of Watershed Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »